OTCMKTS:ICOTF - iCo Therapeutics News Headlines

$0.0910
-0.02 (-14.15 %)
(As of 09/17/2019 01:06 AM ET)
Today's Range
$0.0910
Now: $0.0910
$0.0910
50-Day Range
$0.0418
MA: $0.07
$0.1060
52-Week Range
$0.0290
Now: $0.0910
$0.1060
Volume5,000 shs
Average Volume13,268 shs
Market Capitalization$9.96 million
P/E RatioN/A
Dividend YieldN/A
Beta2.46

Headlines

iCo Therapeutics (OTCMKTS ICOTF) News Headlines

Source:
DateHeadline
iCo Therapeutics Announces Second Quarter 2019 Financial ResultsiCo Therapeutics Announces Second Quarter 2019 Financial Results
finance.yahoo.com - August 29 at 8:39 AM
iCo Therapeutics Inc. Announces the Issuance of 41,200,000 Units Pursuant to its Non-Brokered Private PlacementiCo Therapeutics Inc. Announces the Issuance of 41,200,000 Units Pursuant to its Non-Brokered Private Placement
finance.yahoo.com - August 19 at 11:34 AM
iCo Therapeutics Announces 2018 Year End Financial ResultsiCo Therapeutics Announces 2018 Year End Financial Results
finance.yahoo.com - May 1 at 11:33 AM
iCo Therapeutics Inc. Announces the Issuance of 3,600,000 Units Pursuant to its Non-Brokered Private PlacementiCo Therapeutics Inc. Announces the Issuance of 3,600,000 Units Pursuant to its Non-Brokered Private Placement
finance.yahoo.com - March 5 at 3:56 PM
iCo Therapeutics Announces Third Quarter 2018 Financial Results and Corporate UpdateiCo Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Update
finance.yahoo.com - November 30 at 9:40 AM
iCo Therapeutics Provides Corporate Update, Including Drug Supply for Next Oral Amphotericin B Efficacy StudyiCo Therapeutics Provides Corporate Update, Including Drug Supply for Next Oral Amphotericin B Efficacy Study
finance.yahoo.com - November 15 at 9:18 AM
iCo Therapeutics Announces Oral Amphotericin B Clinical Advisory BoardiCo Therapeutics Announces Oral Amphotericin B Clinical Advisory Board
finance.yahoo.com - October 23 at 8:31 AM
iCo Therapeutics Provides Corporate UpdateiCo Therapeutics Provides Corporate Update
finance.yahoo.com - October 2 at 8:17 AM
iCo Therapeutics Announces Additional Positive Pharmacokinetic Results and Presentation at Global Investment ConferenceiCo Therapeutics Announces Additional Positive Pharmacokinetic Results and Presentation at Global Investment Conference
finance.yahoo.com - September 6 at 3:19 PM
iCo Therapeutics Announces Second Quarter 2018 Financial Results And Corporate UpdateiCo Therapeutics Announces Second Quarter 2018 Financial Results And Corporate Update
finance.yahoo.com - August 30 at 7:25 AM
Ico Therapeutics: 2Q Earnings SnapshotIco Therapeutics: 2Q Earnings Snapshot
finance.yahoo.com - August 30 at 7:25 AM
iCo Therapeutics Hits Primary and Secondary Endpoints in Oral Amphotericin B TrialiCo Therapeutics Hits Primary and Secondary Endpoints in Oral Amphotericin B Trial
www.baystreet.ca - July 16 at 3:16 PM
iCo Therapeutics Announces Positive Secondary Endpoint and Advancement into Later Stage Clinical Trials - Phase 1 Oral Amphotericin BiCo Therapeutics Announces Positive Secondary Endpoint and Advancement into Later Stage Clinical Trials - Phase 1 Oral Amphotericin B
finance.yahoo.com - July 16 at 3:16 PM
iCo Therapeutics Announces Positive Clinical Outcome - Primary Endpoint Met in Phase 1 Oral Amphotericin B StudyiCo Therapeutics Announces Positive Clinical Outcome - Primary Endpoint Met in Phase 1 Oral Amphotericin B Study
finance.yahoo.com - June 27 at 3:17 PM
iCo Therapeutics Provides Corporate Update, Announces Completion of Phase 1 RecruitmentiCo Therapeutics Provides Corporate Update, Announces Completion of Phase 1 Recruitment
finance.yahoo.com - June 20 at 3:15 PM
iCo Therapeutics Announces Third Quarter 2017 Financial ResultsiCo Therapeutics Announces Third Quarter 2017 Financial Results
finance.yahoo.com - November 30 at 11:22 AM
IIROC Trade Halt - iCo Therapeutics Inc.IIROC Trade Halt - iCo Therapeutics Inc.
finance.yahoo.com - November 23 at 2:01 AM
iCo Therapeutics Announces Ethics Approval for its Oral Amphotericin B Phase 1 Clinical StudyiCo Therapeutics Announces Ethics Approval for its Oral Amphotericin B Phase 1 Clinical Study
finance.yahoo.com - November 23 at 2:01 AM
IIROC Trade Resumption - iCo Therapeutics Inc.IIROC Trade Resumption - iCo Therapeutics Inc.
finance.yahoo.com - November 23 at 2:01 AM
What You Must Know About iCo Therapeutics Inc’s (TSXV:ICO) RisksWhat You Must Know About iCo Therapeutics Inc’s (TSXV:ICO) Risks
finance.yahoo.com - September 13 at 1:12 AM
iCo Therapeutics Announces Upcoming Presentations and MeetingsiCo Therapeutics Announces Upcoming Presentations and Meetings
finance.yahoo.com - September 7 at 7:59 PM
iCo Therapeutics Inc. Approves Advance Notice PolicyiCo Therapeutics Inc. Approves Advance Notice Policy
finance.yahoo.com - August 5 at 6:02 AM
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel